Turmoil at CBER: Peter Marks grabs control of FDA's Office of Vaccines ahead of 2 key career leader departures

Zachary Brennan

Senior Editor

FDA’s top vaccine official Peter Marks is pulling the plug on a months-long transition for two top career vaccine officials who abruptly called it quits …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Turmoil at CBER: Peter Marks grabs control of FDA's Office of Vaccines ahead of 2 key career leader departures

Zachary Brennan

Senior Editor

Sign up to read this article for free.

Uro-Oncology Business Manager

ImmunityBio, Inc.

Remote

Trump says he'll sign order on 'most-favored nation' drug price plans Monday

From deal to disaster: Drugmakers face a changed Washington as Trump embraces ‘most favored nation’ prices

Revolution’s KRAS drugs appear competitive in several lung cancer settings

AstraZeneca reports Phase 3 win for Imfinzi; Roche to build new manufacturing site in China

Lilly shuffles key executive positions; Mikael Dolsten takes another post-Pfizer assignment

In one of the riskiest industries — Biotech — a surefire way to neutralize some of that risk emerges

Tur­moil at CBER: Pe­ter Marks grabs con­trol of FDA's Of­fice of Vac­cines ahead of 2 key ca­reer leader de­par­tures

Senior Editor

Sign up to read this article for free.

ImmunityBio, Inc.

Remote

Turmoil at CBER: Peter Marks grabs control of FDA's Office of Vaccines ahead of 2 key career leader departures